XLIFE SCIENCES AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.6 CHF | -2.26% |
|
-1.98% | -30.66% |
| 04-23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| 02-29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Xlife Sciences AG
Price target over the last 5 years
History of analyst recommendation changes
ebdda570fcde661afc16a.9Pc9K475R0ECZ_stfkTZomrUoVX6pkJS7M3Bj81PQbg.pLVZUcvJNSBRDbIVKSLu6ga35CyC7ncetoakvKl3D9ybsnFu_K8_bEcUsg~7d03bfd2d7e554c4df0256f71d5fe900
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
35.4
CHF
Average target price
68
CHF
Spread / Average Target
+92.09%
High Price Target
68
CHF
Spread / Highest target
+92.09%
Low Price Target
68
CHF
Spread / Lowest Target
+92.09%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- XLS Stock
- Consensus Xlife Sciences AG